NCT03862677View on ClinicalTrials.gov

Determining Prognostic Immune Markers in Patients With Ovarian Cancer

RecruitingOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

August 15, 2020

Primary Completion Date

February 1, 2022

Study Completion Date

January 31, 2027

Conditions

Epithelial Ovarian Cancer

Interventions

OTHER

No intervention

Observational study, no intervention

Trial Locations (1)

Unknown

RECRUITING

Leiden University Medical Center, Leiden

All Listed Sponsors

lead

Leiden University Medical Center

OTHER